$PTCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PTC THERAPEUTICS, INC.. Get notifications about new insider transactions in PTC THERAPEUTICS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 34.75 | 83 | 2,884 | 2,742 | 2.8 K to 2.7 K (-2.94 %) |
| Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 34.75 | 297 | 10,321 | 7,446 | 7.7 K to 7.4 K (-3.84 %) |
| Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 34.75 | 409 | 14,213 | 17,538 | 17.9 K to 17.5 K (-2.28 %) |
| Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 34.75 | 339 | 11,780 | 17,947 | 18.3 K to 17.9 K (-1.85 %) |
| Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 34.75 | 1,764 | 61,299 | 24,882 | 26.6 K to 24.9 K (-6.62 %) |
| Dec 18 2018 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Option Exercise | A | 33.63 | 1,167 | 39,246 | 1,167 | |
| Dec 18 2018 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Option Exercise | A | 33.63 | 14,000 | 470,820 | 14,000 | |
| Dec 18 2018 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | A | 33.63 | 1,167 | 39,246 | 1,167 | |
| Dec 18 2018 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | A | 33.63 | 14,000 | 470,820 | 14,000 | |
| Jun 21 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | M | 10.85 | 20,000 | 217,000 | 46,898 | |
| Jun 21 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 48.46 | 12,000 | 581,520 | 17,154 | 29.2 K to 17.2 K (-41.16 %) |
| Jun 21 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 48.09 | 8,000 | 384,720 | 29,154 | 37.2 K to 29.2 K (-21.53 %) |
| Jun 21 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Buy | M | 10.85 | 20,000 | 217,000 | 37,154 | 17.2 K to 37.2 K (+116.59 %) |
| Jun 04 2018 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 34.65 | 5,161 | 178,829 | 63,071 | 68.2 K to 63.1 K (-7.56 %) |
| Jan 09 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 18.03 | 82 | 1,478 | 5,125 | 5.2 K to 5.1 K (-1.57 %) |
| Jan 09 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 18.03 | 621 | 11,197 | 17,154 | 17.8 K to 17.2 K (-3.49 %) |
| Jan 09 2018 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 18.03 | 2,230 | 40,207 | 26,646 | 28.9 K to 26.6 K (-7.72 %) |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 18.01 | 28,000 | 504,280 | 28,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 18.01 | 70,000 | 1,260,700 | 70,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | A | 18.01 | 70,000 | 1,260,700 | 70,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 17.67 | 77 | 1,361 | 5,207 | 5.3 K to 5.2 K (-1.46 %) |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Grant | A | 0.00 | 874 | 0 | 5,284 | 4.4 K to 5.3 K (+19.82 %) |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 18.01 | 2,696 | 48,555 | 2,696 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 18.01 | 75,000 | 1,350,750 | 75,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Grant | A | 0.00 | 1,079 | 0 | 1,742 | 663 to 1.7 K (+162.75 %) |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | A | 18.01 | 40,000 | 720,400 | 40,000 | |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 17.67 | 412 | 7,280 | 6,660 | 7.1 K to 6.7 K (-5.83 %) |
| Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 18.01 | 200,000 | 3,602,000 | 200,000 | |
| Jun 06 2017 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | A | 13.10 | 25,000 | 327,500 | 25,000 | |
| Jun 02 2017 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 12.53 | 30,000 | 375,900 | 30,000 | |
| Jun 02 2017 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Grant | A | 0.00 | 30,000 | 0 | 36,457 | 6.5 K to 36.5 K (+464.61 %) |
| May 25 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,000 | 21,700 | 6,125 | |
| May 25 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,000 | 21,700 | 33,739 | 31.7 K to 33.7 K (+6.30 %) |
| May 24 2017 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Buy | P | 13.49 | 25,000 | 337,230 | 25,000 | 0 to 25 K |
| May 11 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | M | 10.85 | 10,000 | 108,500 | 45,625 | |
| May 11 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Buy | M | 10.85 | 10,000 | 108,500 | 37,850 | 27.9 K to 37.9 K (+35.91 %) |
| May 02 2017 | PTCT | PTC THERAPEUTICS, ... | Complete Pharma Holdings II, L ... | 10% Owner | Sell | J | 0.00 | 6,683,598 | 0 | 0 | 6.7 M to 0 (-100.00 %) |
| Mar 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,966 | 32,181 | 69,227 | |
| Mar 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,966 | 32,181 | 31,739 | 28.8 K to 31.7 K (+10.31 %) |
| Feb 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 72,193 | |
| Feb 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 28,773 | 25.6 K to 28.8 K (+12.18 %) |
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 75,318 | |
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 25,648 | 22.5 K to 25.6 K (+13.87 %) |
| Jan 09 2017 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 06 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 11.82 | 78 | 922 | 2,687 | 2.8 K to 2.7 K (-2.82 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | A | 11.23 | 35,000 | 393,050 | 35,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Grant | A | 0.00 | 720 | 0 | 2,765 | 2 K to 2.8 K (+35.21 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 11.23 | 24,000 | 269,520 | 24,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Renaud Ronald C JR | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | McDonough Cameron Geoffrey | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Ong Tuyen | Chief Medical Offic ... | Option Exercise | A | 11.23 | 35,000 | 393,050 | 35,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Ong Tuyen | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 11.23 | 126,000 | 1,414,980 | 126,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 21,600 | 0 | 28,876 | 7.3 K to 28.9 K (+296.87 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 11.23 | 56,000 | 628,880 | 56,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Grant | A | 0.00 | 9,600 | 0 | 22,523 | 12.9 K to 22.5 K (+74.29 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | A | 11.23 | 52,500 | 589,575 | 52,500 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 27,850 | 18.9 K to 27.9 K (+47.75 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 11.23 | 52,500 | 589,575 | 52,500 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Grant | A | 0.00 | 9,000 | 0 | 27,034 | 18 K to 27 K (+49.91 %) |
| Nov 14 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,941 | 21,060 | 78,443 | |
| Nov 14 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,941 | 21,060 | 11,216 | 9.3 K to 11.2 K (+20.93 %) |
| Oct 11 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,950 | 21,158 | 80,384 | |
| Oct 11 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,950 | 21,158 | 9,275 | 7.3 K to 9.3 K (+26.62 %) |
| Sep 27 2016 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | M | 10.85 | 6,586 | 71,458 | 3,102 | |
| Sep 27 2016 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | M | 10.85 | 3,414 | 37,042 | 66,898 | |
| Sep 27 2016 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Buy | M | 10.85 | 6,586 | 71,458 | 10,000 | 3.4 K to 10 K (+192.91 %) |
| Sep 27 2016 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Buy | M | 10.85 | 3,414 | 37,042 | 3,414 | 0 to 3.4 K |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | M | 10.85 | 60,000 | 651,000 | 0 | |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Buy | M | 10.85 | 60,000 | 651,000 | 86,766 | 26.8 K to 86.8 K (+224.16 %) |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | M | 10.85 | 10,000 | 108,500 | 55,625 | |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Buy | M | 10.85 | 10,000 | 108,500 | 18,850 | 8.9 K to 18.9 K (+112.99 %) |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,200 | 23,870 | 82,334 | |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,200 | 23,870 | 7,325 | 5.1 K to 7.3 K (+42.93 %) |
| Jun 13 2016 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 7.24 | 20,000 | 144,800 | 20,000 | |
| Mar 07 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | P | 6.23 | 2,000 | 12,460 | 5,125 | 3.1 K to 5.1 K (+64.00 %) |
| Jan 15 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 84,534 | |
| Jan 15 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 3,125 | 0 to 3.1 K |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 30.86 | 70,000 | 2,160,200 | 70,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | A | 30.86 | 55,000 | 1,697,300 | 55,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 30.86 | 70,000 | 2,160,200 | 70,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | EVP, CFO & Head of ... | Option Exercise | A | 30.86 | 80,000 | 2,468,800 | 80,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 30.86 | 175,000 | 5,400,500 | 175,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Spiegel Robert J. | Chief Medical Offic ... | Option Exercise | A | 30.86 | 10,000 | 308,600 | 10,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 30.86 | 24,000 | 740,640 | 24,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | McDonough Cameron Geoffrey | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Renaud Ronald C JR | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
| Jul 21 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 9,216 | 99,994 | 87,659 | |
| Jul 21 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 9,216 | 99,994 | 9,216 | 0 to 9.2 K |
| Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 10.85 | 15,000 | 162,750 | 15,000 | |
| Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 48.22 | 700 | 33,754 | 0 | 700 to 0 (-100.00 %) |
| Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 47.50 | 22,904 | 1,087,940 | 700 | 23.6 K to 700 (-97.03 %) |
| Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Buy | M | 10.85 | 15,000 | 162,750 | 23,604 | 8.6 K to 23.6 K (+174.34 %) |
| Jun 19 2015 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 50.13 | 5,000 | 250,650 | 6,848 | 11.8 K to 6.8 K (-42.20 %) |
| Jun 17 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 3,500 | 37,975 | 353,030 | |
| Jun 17 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 3,500 | 37,975 | 7,276 | 3.8 K to 7.3 K (+92.69 %) |
| Jun 11 2015 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 53.90 | 20,000 | 1,078,000 | 20,000 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Option Exercise | M | 10.85 | 50,000 | 542,500 | 50,000 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Option Exercise | M | 10.85 | 12,083 | 131,101 | 7,917 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Sell | S | 56.42 | 3,140 | 177,159 | 16,327 | 19.5 K to 16.3 K (-16.13 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Sell | S | 55.62 | 24,609 | 1,368,753 | 19,467 | 44.1 K to 19.5 K (-55.83 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Sell | S | 54.70 | 18,324 | 1,002,323 | 44,076 | 62.4 K to 44.1 K (-29.37 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Sell | S | 53.87 | 10,776 | 580,503 | 62,400 | 73.2 K to 62.4 K (-14.73 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Buy | M | 10.85 | 50,000 | 542,500 | 73,176 | 23.2 K to 73.2 K (+215.74 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec VP and CLO | Buy | M | 10.85 | 12,083 | 131,101 | 23,176 | 11.1 K to 23.2 K (+108.92 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 26,300 | 285,355 | 356,530 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 17,170 | 186,295 | 382,830 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 60,306 | 654,320 | 110,694 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 54.29 | 400 | 21,716 | 3,776 | 4.2 K to 3.8 K (-9.58 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 53.64 | 13,400 | 718,776 | 4,176 | 17.6 K to 4.2 K (-76.24 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 52.89 | 12,500 | 661,125 | 17,576 | 30.1 K to 17.6 K (-41.56 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 26,300 | 285,355 | 30,076 | 3.8 K to 30.1 K (+696.50 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 56.40 | 3,500 | 197,400 | 3,776 | 7.3 K to 3.8 K (-48.10 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 55.71 | 22,300 | 1,242,333 | 7,276 | 29.6 K to 7.3 K (-75.40 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 54.64 | 36,075 | 1,971,138 | 29,576 | 65.7 K to 29.6 K (-54.95 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 53.81 | 11,825 | 636,303 | 65,651 | 77.5 K to 65.7 K (-15.26 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 17,170 | 186,295 | 77,476 | 60.3 K to 77.5 K (+28.47 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 60,306 | 654,320 | 60,306 | 0 to 60.3 K |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | ALDRICH RICHARD | Director | Option Exercise | M | 10.85 | 7,000 | 75,950 | 13,000 | |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | ALDRICH RICHARD | Director | Sell | S | 56.05 | 104 | 5,829 | 0 | 104 to 0 (-100.00 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | ALDRICH RICHARD | Director | Sell | S | 55.65 | 6,896 | 383,762 | 104 | 7 K to 104 (-98.51 %) |
| Jun 10 2015 | PTCT | PTC THERAPEUTICS, ... | ALDRICH RICHARD | Director | Buy | M | 10.85 | 7,000 | 75,950 | 7,000 | 0 to 7 K |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | M | 27.05 | 18,616 | 503,563 | 46,384 | |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | M | 10.85 | 60,375 | 655,069 | 65,625 | |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Sell | S | 55.93 | 18,450 | 1,031,909 | 8,850 | 27.3 K to 8.9 K (-67.58 %) |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Sell | S | 55.26 | 64,041 | 3,538,906 | 27,300 | 91.3 K to 27.3 K (-70.11 %) |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Buy | M | 27.05 | 18,616 | 503,563 | 91,341 | 72.7 K to 91.3 K (+25.60 %) |
| May 22 2015 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Buy | M | 10.85 | 60,375 | 655,069 | 72,725 | 12.4 K to 72.7 K (+488.87 %) |
| May 19 2015 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 136 | 0 | 0 | 136 to 0 (-100.00 %) |
| May 19 2015 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 2,852 | 0 | 136 | 3 K to 136 (-95.45 %) |
| May 19 2015 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 733 | 0 | 2,988 | 3.7 K to 3 K (-19.70 %) |
| May 11 2015 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 848 | 0 | 3,721 | 4.6 K to 3.7 K (-18.56 %) |
| May 11 2015 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 1,125,722 | 0 | 4,569 | 1.1 M to 4.6 K (-99.60 %) |
| Apr 17 2015 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 69.04 | 4,111 | 283,823 | 0 | 4.1 K to 0 (-100.00 %) |